Allan J Schwartz

US Patent:

6687544, Feb 3, 2004

Filed:

Oct 2, 2001

Appl. No.:

09/970217

Inventors:

Paul A. Levine - Santa Claria CA
Bruce L. Wilkoff - So. Russell OH
Brian M. Mann - Beverly Hills CA
Allan R. Schwartz - Moorpark CA

Assignee:

Pacesetter, Inc. - Sylmar CA

International Classification:

F61N 105

US Classification:

607 27

Abstract:

A system and method for identifying and displaying safety alert advisories. The system of the present invention automatically performs a comparison of identification data with a safety alert advisory. The system stores identification data in a plurality of dedicated fields. Each of the dedicated fields contains information related to the patient. Upon the telemetric retrieval of the data by an external programmer, the external programmer automatically cross-correlates the data in the dedicated fields with the safety alert advisories. Upon identification of a match between the data and one of the safety alert advisories, the identified safety alert advisory is displayed to a medical practitioner. In addition, the system provides a dedicated memory to store an advisory flag. The advisory flag is marked when the programmer identifies a safety alert condition that is relevant to one of the dedicated fields.

US Patent:

20130079836, Mar 28, 2013

Filed:

Sep 27, 2011

Appl. No.:

13/246575

Inventors:

Nishant Srivastava - Los Angeles CA, US
Allan R. Schwartz - Thousand Oaks CA, US
Curtis A. Knight - Santa Clara CA, US

Assignee:

PACESETTER, INC. - Sylmar CA

International Classification:

A61N 1/362
A61N 1/39

US Classification:

607 4

Abstract:

Dynamically switching between different external RF transceivers for communication with an implantable medical device maintains high communication quality in the face of interference, fading, detuning, or other adverse wireless communication conditions. Quality information associated with communications between an implantable medical device and different external devices is monitored to select one,of these external devices to conduct subsequent communication with the implantable medical device. This monitoring is conducted on a repeated basis such that communication is switched to a different RF transceiver whenever such an RF transceiver is able to achieve a higher quality communication than the currently selected RF transceiver. In some embodiments, RF transceivers are deployed in different devices. For example, one or more RF transceivers may be deployed at a portable programmer (e.g., in the form of a computer tablet) and one or more other RF transceivers may be deployed at an associated base station.

US Patent:

20200214567, Jul 9, 2020

Filed:

Mar 6, 2020

Appl. No.:

16/811948

Inventors:

- Los Angeles CA, US
Thomas Chen - La Canada CA, US
Thomas J. Lobl - Valencia CA, US
Jeffrey A. Brydle - Pasadena CA, US
Juan R. Gonzalez - Arleta CA, US
Virote Indravudh - Santa Clarita CA, US
Christian Merot - Ventura CA, US
Allan R. Schwartz - Thousand Oaks CA, US
Chad Srisathapat - Sun Valley CA, US

Assignee:

Cognos Therapeutics Inc. - Los Angeles CA

International Classification:

A61B 5/00
A61B 5/1459
A61B 5/03
A61M 5/142

Abstract:

A skull-mounted drug and pressure sensor (SOS), a smart pump (ISP) electrically coupled to the SOS and a drug delivery and communications catheter communicating the SOS with the ISP are combined for a first embodiment. A skull-mounted (SOS), a metronomic biofeedback pump (MBP) electrically coupled to the SOS and a drug delivery and communications catheter having a sending and receiving optical fiber communicating the SOS with the MBP are combined for a second embodiment. A third embodiment combines a (SOS), an implantable power and communication unit (PCU) electrically coupled to the SOS, and a drug delivery and communications catheter for communicating the SOS with the PCU and for communicating the exterior source of the drug to the SOS. A fourth embodiment combines a ventricular catheter with a CSF accessible chamber and drug delivery port; and an implantable stand-alone skull-mounted drug and pressure sensor (SPS).

US Patent:

20200205663, Jul 2, 2020

Filed:

Mar 6, 2020

Appl. No.:

16/811890

Inventors:

- Los Angeles CA, US
Thomas Chen - La Canada CA, US
Thomas J. Lobl - Valencia CA, US
Jeffrey A. Brydle - Pasadena CA, US
Juan R. Gonzalez - Arleta CA, US
Virote Indravudh - Santa Clarita CA, US
Christian Merot - Ventura CA, US
Allan R. Schwartz - Thousand Oaks CA, US
Chad Srisathapat - Sun Valley CA, US

Assignee:

Cognos Therapeutics Inc. - Los Angeles CA

International Classification:

A61B 5/00
A61B 5/03
A61M 5/142
A61B 5/1459

Abstract:

A skull-mounted drug and pressure sensor (SOS), a smart pump (ISP) electrically coupled to the SOS and a drug delivery and communications catheter communicating the SOS with the ISP are combined for a first embodiment. A skull-mounted (SOS), a metronomic biofeedback pump (MBP) electrically coupled to the SOS and a drug delivery and communications catheter having a sending and receiving optical fiber communicating the SOS with the MBP are combined for a second embodiment. A third embodiment combines a (SOS), an implantable power and communication unit (PCU) electrically coupled to the SOS, and a drug delivery and communications catheter for communicating the SOS with the PCU and for communicating the exterior source of the drug to the SOS. A fourth embodiment combines a ventricular catheter with a CSF accessible chamber and drug delivery port; and an implantable stand-alone skull-mounted drug and pressure sensor (SPS).

US Patent:

20200196868, Jun 25, 2020

Filed:

Feb 28, 2020

Appl. No.:

16/805308

Inventors:

- Los Angeles CA, US
Thomas Chen - La Canada CA, US
Thomas J. Lobl - Valencia CA, US
Jeffrey A. Brydle - Pasadena CA, US
Juan R. Gonzalez - Arleta CA, US
Virote Indravudh - Santa Clarita CA, US
Christian Merot - Ventura CA, US
Allan R. Schwartz - Thousand Oaks CA, US
Chad Srisathapat - Sun Valley CA, US

Assignee:

Cognos Therapeutics Inc. - Los Angeles CA

International Classification:

A61B 5/00
A61M 5/142
A61B 5/03
A61B 5/1459

Abstract:

A skull-mounted drug and pressure sensor (SOS), a smart pump (ISP) electrically coupled to the SOS and a drug delivery and communications catheter communicating the SOS with the ISP are combined for a first embodiment. A skull-mounted (SOS), a metronomic biofeedback pump (MBP) electrically coupled to the SOS and a drug delivery and communications catheter having a sending and receiving optical fiber communicating the SOS with the MBP are combined for a second embodiment. A third embodiment combines a (SOS), an implantable power and communication unit (PCU) electrically coupled to the SOS, and a drug delivery and communications catheter for communicating the SOS with the PCU and for communicating the exterior source of the drug to the SOS. A fourth embodiment combines a ventricular catheter with a CSF accessible chamber and drug delivery port; and an implantable stand-alone skull-mounted drug and pressure sensor (SPS).

US Patent:

20170325685, Nov 16, 2017

Filed:

May 12, 2017

Appl. No.:

15/594251

Inventors:

- Los Angeles CA, US
Thomas Chen - La Canada CA, US
Thomas J. Lobl - Valencia CA, US
Jeffrey A. Brydle - Pasadena CA, US
Juan R. Gonzalez - Arleta CA, US
Virote Indravudh - Santa Clarita CA, US
Christian Merot - Ventura CA, US
Allan R. Schwartz - Thousand Oaks CA, US
Chad Srisathapat - Sun Valley CA, US

Assignee:

Cognos Therapeutics Inc. - Los Angeles CA

International Classification:

A61B 5/00
A61B 5/03
A61B 90/00
A61M 1/00

Abstract:

A skull-mounted drug and pressure sensor (SOS), a smart pump (ISP) electrically coupled to the SOS and a drug delivery and communications catheter communicating the SOS with the ISP are combined for a first embodiment. A skull-mounted (SOS), a metronomic biofeedback pump (MBP) electrically coupled to the SOS and a drug delivery and communications catheter having a sending and receiving optical fiber communicating the SOS with the MBP are combined for a second embodiment. A third embodiment combines a (SOS), an implantable power and communication unit (PCU) electrically coupled to the SOS, and a drug delivery and communications catheter for communicating the SOS with the PCU and for communicating the exterior source of the drug to the SOS. A fourth embodiment combines a ventricular catheter with a CSF accessible chamber and drug delivery port; and an implantable stand-alone skull-mounted drug and pressure sensor (SPS).